Patents

Patent issued for enhanced detection sensitivity in DNA materials analysis

Published in Cancer Weekly, February 8th, 2005

Transgenomic Inc. (TBIO) announced that it has been issued U.S. Patent No. 6,838,242, "Modifying Double Stranded DNA to Enhance Separations by Matched Ion Polynucleotide Chromatography" by the U.S. Patent and Trademark Office.

This patent is part of a set of patents, both issued and pending, for the company's Wave technology that enhance its analytical sensitivity. Some of these technological advances are incorporated the current WAVE HS model and can also be incorporated into certain existing WAVE Systems as an upgrade package.

Collin D'Silva, Transgenomic's CEO, commented that "the introduction of our high-sensitivity detection technology has built...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2005-02-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry